How Investors May Respond To Knowles (KN) Earnings Beat And Guidance

• Knowles reported third quarter 2026 sales of US$184 million and net income of US$21.6 million, alongside detailed guidance for the fourth quarter and full year 2026 that included expected GAAP revenue of US$180 million to US$190 million and diluted EPS from continuing operations of US$0.31 to US$0.35.
• The nine month 2026 figures showed higher sales and earnings compared with the prior year period. Full year revenue guidance of US$689 million, described as 16% above 2025, was presented as reflecting management confidence in demand across Knowles' core end markets.
• We will now assess how Knowles' higher nine month earnings and full year 2026 revenue outlook could reshape the existing investment narrative.

Capitalize on Knowles' updated guidance by scanning a curated 19 high quality undiscovered gems that may be showing similar earnings momentum before it is widely recognised.

Knowles Investment Narrative Recap

To own Knowles, you need to be comfortable with a story built around custom components in medtech, defense and industrial electrification, where factory utilization and product mix do much of the heavy lifting. The latest third quarter and nine month results, together with fresh 2026 guidance, feed directly into that question. They provide more current evidence of how the operating model behaves at today’s volume levels, but they do not remove the execution risk around new lines and capacity additions.

The near term catalyst is straightforward. Investors are watching whether management can keep recent margin gains intact while the specialty film energy order runs through and newer platforms scale. The biggest risk sits on the factory floor. Higher scrap rates, ramp costs or a mix shift toward lower margin work could quickly pull net margins back, particularly with capital spending planned to rise in 2027. The new outlook does not eliminate that tension. It simply updates the scorecard used to track it.

The fourth quarter and full year 2026 guidance on revenues of US$180 million to US$190 million and diluted EPS of US$0.31 to US$0.35 is the announcement that matters most here. It ties directly into the existing thesis around bookings strength, multiyear defense and energy orders and the push into attenuators, inductors and Micro Solutions. When those ranges are read alongside the third quarter and nine month figures, they offer a clearer view of how those projects are currently flowing through to the income statement.

For catalysts, the updated outlook provides a reference point for how much operating leverage Knowles may be getting from higher utilization in Precision Devices and Medtech & Specialty Audio. It also sharpens the downside case. If demand in medtech, defense, industrial or electrification weakens from current levels, or if quality issues surface on the specialty film line, the gap between this guidance and actual delivery may serve as an early signal on both execution and margin resilience.

Knowles' current analyst narrative points to revenues of US$880.3 million and earnings of US$128.0 million by 2029, based on an assumed 9.7% yearly revenue growth rate and an earnings increase of about US$51.6 million from US$76.4 million today.

Discover how Knowles' fair value points to a 27% potential upside relative to its current price before that discount closes.

Exploring Other Perspectives

One alternate view on Knowles leans heavily on valuation risk. The more cautious analysts were working off a US$35.0 price target, tied to 2029 revenue of about US$842.9 million and earnings of US$126.4 million. That is only modestly below consensus, yet paints a flatter story that this new guidance could eventually challenge.

Explore 3 other Knowles fair value estimates, including one that suggests as much as 52% downside from the current price!

Decide For Yourself

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

• A great starting point for your Knowles research is our analysis highlighting 3 key rewards that could impact your investment decision.
• See our latest analysis for Knowles. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Knowles' overall financial health at a glance.

Looking For More Investment Ideas Beyond Knowles?

Once you have a view on Knowles, it can help to compare it with other opportunities that share similar qualities or offer a different risk profile. The Simply Wall St Screener lets you do that quickly, using the same data-driven approach across hundreds of stocks.

• If you care most about quality at a reasonable entry point, scan a curated set of companies through 26 high quality undervalued stocks that may align better with your return and risk expectations.
• If capital preservation is higher on your list, filter for businesses with steadier profiles using a 32 resilient stocks with low risk scores that focuses on more resilient characteristics.
• If balance sheet strength is your priority, start with a list of solid balance sheet and fundamentals (24 results) that highlights companies with funding structures that may better support through-cycle performance.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com